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This report documents for the tirst time the existence of spechic binding proteins for hyaluronic acid binding protein (hyaluronectin) in the plasma 
membranes of normal and transformed cells. Firstly, we showed the specific binding of hyaluronic acid binding protein to the cell surface of normal 
rat heart fibroblasts (NRHF) by saturation and competition methods using ‘*‘I-labeled hyaluronic acid binding protein and calculated the binding 
dissociation constant (0.43 x lo-” M). In order to identify hyahtronectin-binding protein on the cell surface, plasma membranes i olated from rat 
brain, liver and fibrosarcoma were separated by SDS-PAGE and transferred to nitrocellulose paper by electroblotting. Incubation of the transferred 
membrane proteins with ‘251-lab&d hyaluroneotin in the presence of non-ionic as well as ionic detergents revealed two prominent bands of 
approximate molecular mass of 37 kDa and 40 kDa in brain, liver and fibrosarcoma. The specificity of the binding [‘251Jhyaluronectin to 37-kDa 
and 40-kDa membrane proteins was further conIirmed, as the intensity of the bands was reduced in the presence of a 20-fold excess of unlabeled 
hyaluronectin. We discuss our observations on hyalmonectin-binding membrane proteins in the context of hyalmonectin-mediated cellular 
functions. 
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1. INTRODUCTION 
Cell-matrix and cell-cell interactions are fundamen- 
tal requirements in a number of cellular functions such 
as proliferation, differentiation and transformation. 
Such interactions occur through specific cell surface re- 
ceptor systems that bind to extracellular adhesive pro- 
teins, and provide these a putative transmembrane link 
to intracellular cytoskeletal components. Recently, a 
family of cell adhesion receptors, termed ‘integrins’, has 
been described that is functionally implicated in each of 
these biological events [l-3]. The integrins include the 
receptor of ECM proteins [4-91 and promote cell attach- 
ment to their extracellular ligands. Besides integrins, 
several other cell surface binding proteins or cell surface 
receptors for laminin and collagens have also been char- 
acterized from various cell types [2,10] and are impli- 
cated in cell-matrix or cell-cell interactions. Laminin 
binding proteins with higher affinity apparently consist 
of a single 67-kDa to 180-kDa glycoprotein, and are 
functionally as well as structurally distinct from integrin 
receptors [lo]. 
Recently, we have reported the isolation and charac- 
terization of hyaluronectin, a homodimeric glycopro- 
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tein of 34-kDa subunits, as a principal binding site for 
hyaluronan in the extracellular matrices [111. Its localiz- 
ation on the cell surface and involvement in the cell- 
substratum adhesion, as well as, its participation in the 
cell-cell interaction during solid tumor formation by 
transformed histiocytic macrophages has also been re- 
ported [12]. As with other ECM adhesive proteins dis- 
cussed above, these biological effects of hyaluronectin 
on cells are thought to be mediated through specific 
cell-surface receptors or binding proteins in the plasma 
membranes. 
In order to understand the mechanism of regulation 
of the cell functions mediated by hyaluronectin-cell in- 
teraction, we attempted to identify hyaluronectin-bind- 
ing site on the cell surface. 
2. MATERIALS AND METHODS 
2.1. Materials 
Unless and otherwise mentioned, chemicals were purchased from 
Sigma Chemicals Co., St. Louis, USA. Molecular weight markers for 
SDS-PAGE and AH-Sepharose 4B were obtained from Pharmacia 
Fine Chemicals, Uppsala, Sweden. [‘*‘IJIodine was purchased from 
BARC, India. X-omat AR X-ray 8hns were purchased from the East- 
man Kodak Company, Rochester, NY 12650, USA. 
2.2. Preparation of plasma membranes 
Plasma membranes were isolated from rat liver essentially following 
the method of Ray [13], using discontinuous ucrose density gradient 
composed of 452, 41% and 37% sucrose (w/w). Rat brain plasma 
membranes were prepared according to Havrankova and Roth [14] 
and Hajos [ 151 using discontinuous ucrose density gradient made up 
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of 1.2 M and 0.8 M sucrose (w/w). Plasma membrane of ascitic fibro- 
sarcoma cells were isolated over a 41% sucrose solution according to 
Maeda et al. [16]. Liver plasma membranes from the 37% to 41% 
sucrose interface and brain plasma membranes from the 0.8 to 1.2 M 
sucrose interface and fibrosarcoma plasma membranes as white inter- 
facial band were collected and washed with 0.01 M phosphate-buffer- 
ed saline (PBS), pH 7.2 and stored at -7O’C. 
2.3. PuriJication of hyaluronectin and protein labeling 
68-kDa hyaluronectin was purified from adult rat kidney according 
to our previous method using ammonium sulphate fractionation and 
hyaluronate-sepharose chromatography [1 I]. 68-kDa hyaluronectin 
was radiolabeled with [‘?]iodine to a specific activity (1.4 x 10’ cpm/ 
pg of protein for blotting experiments and 1.09 x lo3 cpm/pg of pro- 
tein for binding assay), using the Iodogen method described by Fraker 
and Speck [17]. 
2.4. Binding of [“‘Ijhyaluronectin to cells (hyaluronectin-cell binding 
assay) 
Hyaluronectin-cell binding assays were performed with NRHF 
cells grown in monolayers using radiolabeled ligand, i.e. “‘I-labeled 
hyaluronectin following the method of Turley et al. [18] with some 
modifications. 
The NRHF were plated on to 24-well tissue culture plastic plates 
(Coster) at a density of 1 x lo6 cells per well in DMEM supplemented 
with 10% FCS, 100 units/ml penicillin, and 100 @ml streptomycin. 
The fibroblasts were incubated in this medium for 24 h at 37°C and 
5% CO, until monolayers formed in the wells. The monolayers were 
incubated with 0.2 M urea in the same medium containing 1% FCS 
for 24 h at 37°C to expose the binding sites of hyaluronectin. The cells 
were then washed several times in DMEM containing cycloheximide 
(0.2,@ml) to prevent resynthesis of surface materials removed by urea 
treatment [19]. Before the binding assay, the fibroblast monolayers 
pretreated with urea were blocked by incubation with 0.1% BSA in 
serum-free DMEM for 2 h at 37“C. This was followed by incubation 
with increasing amounts (2 to 30 ng/ml per well) of [“‘I]hyaluronectin 
(specific activity 1.09 x 10’ cpm/ng of protein) in serum-free DMEM 
containing 0.2 pg cycloheximide/ml for 20 min at 37°C. In all cases 
the final volume of incubation mixture was kept 1.0 ml/well. Identical 
binding studies were also carried out using NRHF monolayers that 
were not treated with urea. After binding incubation, unbound 
[Ylhyaluronectin was removed by washing the cells four times with 
serum-free DMEM. The cells were then solubilized in 0.1 M NaOH. 
Both cell-bound and unbound radioactivity were counted in a gamma- 
counter. The cell protein was measured by Lowry et al. [20]. 
Specificity of the binding of [‘251]hyaluronectin was tested by the 
competition of radiolabeled hyaluronectin with excess unlabeled hy- 
aluronectin for binding. For the competition assay, a fixed amount of 
[‘Z51]hyaluronectin (i.e. the concentration at saturation level, 28 @ml/ 
well) and increasing amounts (5- to SO-fold excess) of unlabeled hy- 
aluronectin were added to the cells, and the decrease in binding of 
[‘251]hyaluronectin with increasing competition by unlabeled hy- 
aluronectin was measured with the above protocol. 
2.5. Western blotting of plasma membranes with ‘2SI-labeled 
hyaluronectin 
To identify hyaluronectin-binding proteins, Western blotting of 
plasma membranes of brain, liver and fibrosarcoma with [‘Z51]hy- 
aluronectin was performed according to Lesot et al. [21]. Purified liver, 
brain, and fibrosarcoma plasma membrane proteins were separated 
in 0.1% SDS on 12.5% polyacrylamide slab gel using discontinuous 
buffer system described by Laemmli [22] and then electroblotted on 
nitrocellulose sheets [23]. After washing briefly in 0.01 M PBS, pH 7.2 
containing 0.05% Tween-20 (PBST), the sheets upporting transferred 
materials were saturated with 3% BSA in PBST at 37°C for 2 h. The 
sheets were washed with PBST and incubated with [‘251]hyaluronectin 
(sp. activity 1.4 x lo5 cpm/pg of hyaluronectin) in PBS containing 1% 
BSA and 0.05% Tween-20 overnight at room temperature. After wash- 
ing all the NC sheets exhaustively with PBST, the NC sheets were 
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dried and exposed to Kodak X-omat AR films for autoradiography. 
Specific binding of [‘251]hyaluronectin to membrane proteins was 
tested by adding a 20-fold excess of unlabeled hyaluronectin to the 
incubation solution. 
In order to eliminate non-specific or low-specificity binding, [‘*‘I]hy- 
aluronectin incubations and washings were performed under condi- 
tions of elevated stringency, i.e. using PBS containing Na-deoxycho- 
late (ionic detergent). 
3. RESULTS 
To characterize the mode of association of extracellu- 
lar 68-kDa hyaluronectin with the cell surface, we stud- 
ied the binding of hyaluronectin to the cell surface of 
intact normal rat heart fibroblasts (NRHF) by the satu- 
ration and competition methods using *251-labeled hy- 
aluronectin. As shown in Fig. la [‘251]hyaluronectin, 
added in increasing amounts (i.e. 2 to 30 ng per well in 
serum-free DMEM) to intact urea-pretreated or un- 
treated monolayers of NRHF, bound in a linear and 
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Fig. l(a). Saturation of binding of [‘251]hyaluronectin to intact urea- 
pretreated or untreated normal rat heart fibroblasts (NRHF) mono- 
layers. The assay of [‘Z51]hyaluronectin binding to NRHF was carried 
out as described in section 2. The monolayer cultures (approximately 
lo6 cells/well) were pretreated with 0.2 M urea to expose cell-surface 
binding sites for hyaluronectin (M), or with culture medium only 
(O---O). Monolayers were washed in DMEM containing 0.2 ,ug/ml of 
cycloheximide, and then incubated with increasing amounts of [‘251]hy- 
aluronectin (specific activity 1.09 x 10’ cpm/ng of protein) in serum- 
free DMEM for 90 min at 37°C. After binding incubation, the mono- 
layers were washed, solubiliied in 0.1 M NaOH, and then counted for 
the cell-bound radioactivity in a gamma-counter. The cell-bound radi- 
oactivity (i.e. cell-bound [‘251]hyaluronectin in cpm/106 cells) is plotted 
as a function of the amount of the added radiolabeled hyaluronectin. 
Values represent the mean f S.D. of six replicates from one assay. The 
entire assay was repeated at least twice with similar results. Hy- 
aluronectin has been termed as HABP in photograph. 
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saturable manner. However, [‘251]hyaluronectin bound 
in greater amounts to urea pretreated than to untreated 
fibroblasts (Fig. la), implying that the urea treatment 
exposed binding sites for hyaluronectin on the cell sur- 
face. 
Scatchard plot [24] analysis of the binding of [‘*‘I]hy- 
aluronectin to intact urea pretreated and untreated 
NRHF demonstrated only a single class of binding sites 
for hyaluronectin on the surface of the cells with appar- 
ent dissociation constants (Kd) of 0.43 x lo-l3 M and 
2 x lo-l3 M respectively (Fig. lb). 
The specificity of [‘251]hyaluronectin bi ding to these 
cells was confirmed by the observation that the addition 
of increasing amounts of unlabeled hyaluronectin along 
with a constant amount of [1251]hyaluronectin progres- 
sively reduced the binding of [‘251]hyaluronectin o the 
cells, which further confirms the specificity of the bind- 
ing (Fig. 2). In order to identify the specific hy- 
aluronectin binding protein, the plasma membrane pro- 
teins of brain, liver and fibrosarcoma were prepared by 
sucrose density gradient. The proteins were separated 
by SDS-PAGE and transferred to nitrocellulose paper 
by electroblotting. The plasma membrane hy- 
aluronectin acid binding protein has been identified by 
overnight incubation of this nitrocellulose paper with 
[‘251]hyaluronectin in the presence of non-ionic deter- 
gent with or without excess of unlabeled hyaluronectin. 
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Fig. l(b). Scatchard analysis of the binding of [‘*‘I]hyaluronectin to 
urea-pretreated and untreated NRHF cells. The binding data for urea- 
pretreated (u) and untreated (A-A) cells (obtained in the absence 
of unlabeled hyaluronectin) were analyzed by plotting the ratio of the 
bound concentration of radiolabeled hyaluronectin to the free concen- 
tration as a function of the bound concentration of radiolabeled hy- 
aluronectin. The scatchard plot analysis was used to determine K, 
(slope) for the hyaluronectin binding to urea pretreated and untreated 
fibroblasts. Hyaluronectin has been termed as HABP in photograph. 
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Fig. 2. Inhibition of binding of [“‘Ilhyaluronectin to intact urea- 
pretreated or untreated NRHF monolayers by increasing amounts of 
unlabeled hyaluronectin. The competition binding assays were per- 
formed as described in section 2. The intact urea-pretreated or un- 
treated monolayer cultures of NRHF (approximately lo6 cells/well) 
were incubated with a constant amount (28 @ml/well) of [‘251]hy- 
aluronectin plus increasing amounts (5- to 50-fold excess) of unlabeled 
hyaluronectin in serum-free DMEM for 90 min at 37°C. The mono- 
layers were then washed, solubilized in 0.1 M NaOH, and subse- 
quently counted for cell-bound radioactivity in a gamma-counter. The 
cell-bound radioactivity (i.e. cell-bound [‘?]hyaluronectin in cpm/ 
lo6 cells is plotted as a function of amount of the added unlabeled 
hyaluronectin. Values represent the mean f S.D. of six replicates from 
one assay. The entire assay was repeated at least twice with similar 
results. (O-O), (O---O) Urea-pretreated and untreated NRHF cells, 
respectively. Hyaluronectin has been termed as HABP in the photo- 
graph. 
After extensive washing with non-ionic detergent, two 
prominent bands of 37 kDa and 40 kDa were detected 
after autoradiography (Fig. 3A and B). Binding of 
[‘*‘I]hyaluronectin to these protein bands was sup- 
pressed in the presence of a 20-fold excess of the unla- 
beled hyaluronectin, which suggested that the binding 
was specific (Fig. 3A, lanes 3 and 5, Fig. 3B, lane 3). 
Further, when hyaluronectin incubation and washings 
were performed under elevated ionic strength (i.e. in the 
presence of ionic detergent), the [1251]hyaluronectin still 
bound specifically to these membrane protein bands at 
37 kDa and 40 kDa (Fig. 3A, lane 4, Fig. 3B, lane 2). 
Preferential binding of [‘251]hyaluronectin to 37-kDa 
and 40-kDa membrane proteins even in the presence of 
ionic detergent and its reduced affinity in the presence 
of the excess unlabeled hyaluronectin confirm that 37- 
kDa and 40-kDa membrane proteins are specific hy- 
aluronectin binding proteins in the plasma membrane 
of rat brain, liver cell and fibrosarcoma. As results are 
513 
Volume 336, number 3 FEBS LETTERS December 1993 
(A) 
kDa 
(B) 
Fig. 3A and B. Binding of ‘251-labeled 68-kDa hyaluronectin to plasma 
membrane proteins of rat brain (A) and fibrosarcoma (B), plasma 
membranes were collected on a sucrose gradient and separated by 
12.5% SDS-PAGE. After transfer to NC paper by electroblotting, 
sheets were incubated with [‘251]hyaluronectin, washed and autoradi- 
ographed as mentioned in section 2. Lanes Al and Bl, total plasma 
membrane proteins of rat brain (Al) and fibrosarcoma (Bl) after 
electrophoresis and staining with Coomassie blue. Lanes 2-5 (A), 
autoradiograph after staining and incubation with [‘251’Jhyaluronectin 
shows preferential binding of [‘2sI]hyaluronectin to two membrane 
proteins of 37 kDa and 40 kDa in the presence of non-ionic detergent 
without excess of unlabeled hyaluronectin (A2); non-ionic detergent 
with a 20-fold excess of unlabeled hyaluronectin (A3); ionic detergent 
without excess of unlabeled hyaluronectin (A4); ionic detergent with 
a 20-fold excess of unlabeled hyaluronectin (A5). Lane B2, non-ionic 
and ionic detergent without excess of unlabeled hyaluronectin. Non- 
ionic and ionic detergent with a 20-fold excess of unlabeled hy- 
aluronectin (B3). Low molecular weight markers (lanes A6 and B4) 
were stained with Amid0 black staining. 
the same for liver and brain, no separate photograph is 
given for the liver experiment. 
4. DISCUSSION 
The presence of 37-kDa and 40-kDa binding proteins 
for hyaluronectin in plasma membrane is further justi- 
fied as there are increasing evidences for the existence 
of integral membrane proteins in small molecular 
weight range in various cell types and tissues, which are 
involved in cell-matrix or cell-cell interaction and are 
distinct from integrins [2]. The smaller sized and mon- 
omeric collagen-binding membrane proteins ranging in 
size from 31-kDa to 37-kDa have been identified more 
recently [2]. It is interesting that the afiity of hy- 
aluronectin binding protein for hyaluronectin is similar 
to the 67-kDa to 70-kDa monomeric laminin-binding 
protein, which also have high affinity for laminin, bind- 
ing well even after solubilization in SDS and blotting 
onto nitrocellulose [10,21]. 
In recent years, rapid progress has been made in un- Although our data clearly show the existence of spe- 
derstanding the molecular interactions that result in cell cific hyaluronectin binding proteins in the plasma mem- 
adhesion. It is becoming clearer only now that extracel- branes of rat brain, liver and fibrosarcoma, they are 
lular adhesive proteins and their specific cell surface fragmentary, and do not yet indicate the homology of 
receptors play an important role in cell-matrix and cell- these hyaluronectin-binding membrane proteins with 
cell adhesion in many physiologically important proc- the known cell surface receptors for binding proteins for 
esses including oncogenic transformation, and are key extracellular adhesive proteins. A precise structural 
components of the cellular communication network. comparison can be made in future only after the isola- 
Thus, in this context the present study documents the tion and characterization of hyaluronectin binding pro- 
following important observations: (a) linear and satura- tein. 
ble binding of exogenous [“‘I]hyaluronectin to normal 
rat heart fibroblasts demonstrating the existence of spe- 
cific binding sites for this protein on cell membrane; and 
finally (b) the identification of hyaluronectin binding 
proteins of molecular mass of 37 kDa and 40 kDa in the 
plasma membrane of brain, liver and fibrosarcoma. 
The 37-kDa and 40-kDa membrane components are 
shown to be specific hyaluronectin-binding proteins, as 
[i2-Y]hyaluronectin binds to these membrane proteins 
even in the presence of ionic detergents. Moreover, the 
reduced binding of [“‘I]hyaluronectin to 37-kDa and 
40-kDa membrane proteins in the presence of a 20-fold 
excess of unlabeled hyaluronectin contirms the specific- 
ity of the binding of hyaluronectin to these proteins. 
This observation is supported by our early report [12] 
that hyaluronectin stimulates cell-substratum attach- 
ment which can be specifically blocked by its antibody. 
It is important to mention that hyaluronectin-mediated 
cell-substratum attachment is independent of its ligand, 
i.e. HA. The crucial role of hyaluronectin-cell interac- 
tion in cell--cell adhesion was further evident from our 
previous finding [12] that pretreatment of virally trans- 
formed histiocytic macrophages with anti-hy- 
aluronectin antibodies abolished their capacity to grow 
as solid tumors. In the light of the cell adhesive property 
[12] of hyaluronectin, our present results on the exis- 
tence of hyaluronectin-binding proteins in the plasma 
membranes perhaps may shed light on the mechanisms 
by which hyaluronectin interacts with cells and then 
mediates physiologically important processes especially 
those which involve transmembrane signal transmis- 
sion. 
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